In this study, we used PTEN-functional MDA-MB-231 breast cancer cells stably expressing the genetically encoded Ca2+ indicator GCaMP6m (GCaMP6m-MDA-MB-231) as a model to assess the direct consequence of PTEN loss on Ca2+ signaling. Here, PTEN is linked to breast cancer.